Trial Profile
Comparison of rate of infections in patients with Psoriasis treated with Ustekinumab versus standard oral systemic therapeutic agents (acitretin, cyclosporine, or methotrexate):RADAR project
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary) ; Acitretin; Ciclosporin; Methotrexate
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms RADAR
- 08 Jun 2017 New trial record